Zomedica Corp. reiterated revenue guidance for full year 2024. For the period, the company expects revenue in the range of $31 to $35 million, an increase of approximately 40% at the high end of the range, over full year 2023 revenue of $25.2 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.156 USD | -4.53% | -10.09% | -22.08% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.08% | 153M | |
-30.30% | 1.08B |
- Stock Market
- Equities
- ZOM Stock
- News Zomedica Corp.
- Zomedica Corp. Reiterates Revenue Guidance for Full Year 2024